Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis
Abroad (travel likely)RecruitingPHASE2
Conditions
Hepatocellular Carcinoma Non-resectable
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Grenoble, Grenoble, France
CHU de Lille, Lille, France
La Timone, Marseille, France
CHU de Montpellier, Montpellier, France
CHU de Nice, Nice, France
Centre Eugène Marquis, Rennes, France
Study leads
Etienne Garin, MD PHD
Principal Investigator
Centre de Lutte Contre Le cancer Eugène Marquis